3Caira FC, Stock SR, Gleason TG, et al . Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation[J]. J Am Coll Cardiol , 2006,47 (8) : 1707-1712.
4Otto CM,Lind BK,Kitzman DW, et al . Association of aorticvalve sclerosis with cardiovascular mortality and morbidity in the elderly[J]. N Engl J Med ,1999,341:142-147.
7Kaden JJ, Bickelhaupt S, Grobholz R, et al . Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification[J]. J Mol Cell Cardiol , 2004, 36:57-66.
8Pohjolainen V, Taskinen P, Soini Y, et al . Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation[J]. Hum Pathol ,2008,39(11) :1695-1701.
9Mohler ER,Gannon F,Reynolds C, et al . Bone formation and inflammation in cardiac valves[J]. Circulation , 2001, 103: 1522.
10Steitz SA,Speer M Y,McKee MD, et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification[J]. Am J Pathol , 2002,161 : 2035-2046.
6[3]Rosenhek R,Binder T,Porenta G,et al.Predictors of outcome in severe,asymptomatic aortic stenosis[J].N Engl J Med,2000,342:611-617.
7[4]Kwan-Leung Chart,MD,FRCPC.FACC.Is aortic stenosis a preventable disease?[J].J Am Coll Cardiol,2003,42:593-599.
8[5]Novaro GM,Tiong IY,Pearce GL,et al.Effect of hydroxymethylglutaryl cocnzyme a reductase inhibitors on the progression of calcific aortic stenosis[J].Circulation,2001,104:2205-2209.
9[6]Aronow WS,Alan C,Kronzon I,et al.Association of coronary risk factors and USe of statins with progression of mild valvular aortic stenosis in older persons[J].Am J Cardiol,2001,88:693-695.
10Fulkerson PK, Beaver BM, Auseon JC, et al . Calcification of the mitral annulus:etiology,clinical association,complications and therapy[J].Am J Med, 1979; 66: 967-77.
